Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F
- Author
- TEFFERI, Ayalew1 ; ELLIOTT, Michelle1
[1] Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, United States - Issue title
- Hemostatic dysfunction in malignant hematologic disorders
- Author (monograph)
- KWAAN, Hau C (Editor)1
[1] Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States - Source
Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 4, pp 313-320, 8 p ; ref : 72 ref
- CODEN
- STHMBV
- ISSN
- 0094-6176
- Scientific domain
- Cardiology, blood circulation, phlebology; Hematology
- Publisher
- Thieme, New York, NY
/
Thieme, Stuttgart
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- JAK2 Thrombosis myeloproliferative polycythemia thrombocythemia
- Keyword (fr)
- Epidémiologie Leucocyte Myéloprolifératif syndrome Polyglobulie Pronostic Protein-tyrosine kinase Prévalence Thrombocytémie Thrombose JAK2 protein tyrosine kinase Appareil circulatoire pathologie Enzyme Hémopathie Transferases Vaisseau sanguin pathologie
- Keyword (en)
- Epidemiology Leukocyte Myeloproliferative syndrome Polycythemia Prognosis Protein-tyrosine kinase Prevalence Thrombocythemia Thrombosis JAK2 protein tyrosine kinase Cardiovascular disease Enzyme Hemopathy Transferases Vascular disease
- Keyword (es)
- Epidemiología Leucocito Mieloproliferativo síndrome Policitemia Pronóstico Protein-tyrosine kinase Prevalencia Trombocitemia Trombosis JAK2 protein tyrosine kinase Aparato circulatorio patología Enzima Hemopatía Transferases Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A04 Molecular and cellular biology / 002A04I Blood coagulation. Blood cells
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19C Platelet diseases and coagulopathies
- Discipline
- Blood diseases Molecular and cell biology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18942655
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1055/s-2007-976165 
https://dx.doi.org/10.1055/s-2007-976165
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"320\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TEFFERI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ayalew\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"ELLIOTT, Michelle\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:57:\"Hemostatic dysfunction in malignant hematologic disorders\";s:8:\"\u0000*\u0000title\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"320\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TEFFERI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ayalew\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"ELLIOTT, Michelle\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:57:\"Hemostatic dysfunction in malignant hematologic disorders\";s:8:\"\u0000*\u0000title\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"320\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TEFFERI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ayalew\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"ELLIOTT, Michelle\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:57:\"Hemostatic dysfunction in malignant hematologic disorders\";s:8:\"\u0000*\u0000title\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"320\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TEFFERI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ayalew\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"ELLIOTT, Michelle\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:57:\"Hemostatic dysfunction in malignant hematologic disorders\";s:8:\"\u0000*\u0000title\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-976165\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"313\";s:8:\"\u0000*\u0000epage\";s:3:\"320\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"TEFFERI\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ayalew\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"ELLIOTT, Michelle\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:57:\"Hemostatic dysfunction in malignant hematologic disorders\";s:8:\"\u0000*\u0000title\";s:117:\"Thrombosis in myeloproliferative disorders : Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
